the impact of long acting injectables on schizophrenia
Published 5 months ago • 2.7K plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
0:44
do clinicians introduce clozapine too late for the treatment of schizophrenia?
-
0:53
is the traditional definition of treatment-resistant schizophrenia still relevant?
-
0:36
are you familiar with the varied presentations of catatonia in schizophrenia?
-
0:40
short vs. long-term stressors & their impact
-
1:00
the origin of fear and trauma – where does it all start?
-
0:56
what clinicians should consider when switching antipsychotics
-
1:00
the power of psychodynamic psychotherapy…
-
0:59
mechanism of action of agomelatine - antidepressant effects #agomelatine #valdoxan #psychiatry
-
0:44
the overlooked cases of trauma without ptsd (clinicians much watch)
-
0:30
dr stephen stahl interview by dr sanil rege
-
0:32
long-acting injectables preserve brain tissue and prevent relapse
-
1:00
how stress can improve performance (and also hinder it)
-
0:46
“combine mechanisms, not drugs” – 2 key principles in psychopharmacology
-
0:51
the benefits of long-acting injectables in schizophrenia, part 2
-
11:38
patient selection and holistic treatment in schizophrenia by prof bernhard baune
-
0:45
“oxidative stress alters the expression of genetics…
-
0:45
the benefits of long-acting injectables in schizophrenia, part 1
-
1:00
the causes and mechanisms behind metabolic syndrome